Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Sandig

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
BMC Proceedings|March 1, 2012
Characterisation of cultivation of the human cell line AGE1.HN.AATEva Schräder, Sebastian Scholz, Jens Niklas, et al.
BMC Proceedings|March 1, 2012
Criteria for bioreactor comparison and operation standardisation during process development for mammalian cell cultureOscar Platas Barradas, Uwe Jandt, Linh Da Minh Phan, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 18, 2011
A chemically defined production process for highly attenuated poxvirusesIngo Jordan, Stefan Northoff, Michael Thiele, et al.
BMC Proceedings|March 1, 2012
Increasing antibody yield and modulating final product quality using the Freedom(TM) CHO-S(TM) production platformMichelle Sabourin, Ying Huang, Prasad Dhulipala, et al.
Journal of Virology|September 21, 2018
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular CarcinomaSarah Abdullahi, Melanie Jäkel, Sabine J Behrend, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2024
Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tractHana Esih, Klemen Mezgec, Martina Billmeier, et al.
The Journal of General Virology|October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccineMartina Pfranger, Nina Krause, Benedikt Asbach, et al.
NPJ Vaccines|September 9, 2024
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variantsSneha Vishwanath, George William Carnell, Martina Billmeier, et al.
Frontiers in Immunology|March 13, 2023
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variantsGeorge W Carnell, Martina Billmeier, Sneha Vishwanath, et al.
Nature Biomedical Engineering|September 25, 2023
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecovirusesSneha Vishwanath, George William Carnell, Matteo Ferrari, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
BMC Proceedings|March 1, 2012
Characterisation of cultivation of the human cell line AGE1.HN.AATEva Schräder, Sebastian Scholz, Jens Niklas, et al.
BMC Proceedings|March 1, 2012
Criteria for bioreactor comparison and operation standardisation during process development for mammalian cell cultureOscar Platas Barradas, Uwe Jandt, Linh Da Minh Phan, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 18, 2011
A chemically defined production process for highly attenuated poxvirusesIngo Jordan, Stefan Northoff, Michael Thiele, et al.
BMC Proceedings|March 1, 2012
Increasing antibody yield and modulating final product quality using the Freedom(TM) CHO-S(TM) production platformMichelle Sabourin, Ying Huang, Prasad Dhulipala, et al.
Journal of Virology|September 21, 2018
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular CarcinomaSarah Abdullahi, Melanie Jäkel, Sabine J Behrend, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2024
Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tractHana Esih, Klemen Mezgec, Martina Billmeier, et al.
The Journal of General Virology|October 6, 2025
Immunogenicity of a trivalent haemorrhagic fever vaccine candidate against Sudan virus, Marburg virus and Lassa virus in an mpox vaccineMartina Pfranger, Nina Krause, Benedikt Asbach, et al.
NPJ Vaccines|September 9, 2024
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variantsSneha Vishwanath, George William Carnell, Martina Billmeier, et al.
Frontiers in Immunology|March 13, 2023
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variantsGeorge W Carnell, Martina Billmeier, Sneha Vishwanath, et al.
Nature Biomedical Engineering|September 25, 2023
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecovirusesSneha Vishwanath, George William Carnell, Matteo Ferrari, et al.
Pageof 7